Nutranomics, Inc. (NNRX)

Market Cap	16.75K
Revenue (ttm)	n/a
Net Income (ttm)	25.93K
Shares Out	16.75B
EPS (ttm)	0.00
PE Ratio	0.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	345,000
Average Volume	355,376
Open	0.0000
Previous Close	n/a
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0001
Beta	1.40
RSI	45.47
Earnings Date	n/a

About Nutranomics

Nutranomics, Inc. engages in the research, development, and sale of nutritional food products. It offers approximately 480 nutritional supplements, including formulating vitamin, mineral, herbal, and probiotic supplements. The company provides Nutritional Blood Analysis, a tool to examine the customer’s blood cells on a video monitor, live, in real time; and the patented Assimilation Enhancing System that improves the absorption of nutrients. In addition, it offers educational services, including various types of analyses, trainings, certificat...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: NNRX

Financial Performance

In 2020, Nutranomics's revenue was $871, a decrease of -98.54% compared to the previous year's $59,544. Losses were -$950,795, -57.52% less than in 2019.